810222P

C6-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810222P, powder

• Synonym(e): N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
• Empirische Formel (Hill-System): C₃₆H₅₉N₅O₁₁
• CAS-Nummer: 94885-03-7
• Molekulargewicht: 737.88
• MDL-Nummer: MFCD00870345
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (810222P-1MG); pkg of 1 × 250 μg (810222P-250ug)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810222P
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Biochem./physiol. Wirkung

The synthesis of glucosyl ceramide (GlcCer) occurs in the cytosolic membranes of Golgi. It is catalysed by GlcCer synthase. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.[1] C6-NBD glcCer is useful to view ceramide rich membrane domains in Golgi compartments.[2]

Verpackung

5 mL Amber Glass Screw Cap Vial (810299P-1MG)

5 mL Clear Glass Sealed Ampule (810222P-250ug)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available